Two different studies are discussed. In the first, 67 subjects with neuromuscular diseases were interviewed to study their mental state and features of their personality as functions of disability. Female subjects had a higher aggression level than male subjects. Aggression in different forms seemed to function as a coping mechanism for the female disabled subjects whereas denial and withdrawal were more typical for the males. Due to unsolved crises, unstated fear of the future and/or death or forlornness and the poor ability to form positive social relationships, the subjects had limited psychological resources to cope with the extremely stressful situation caused by disability and progressive diseases. In the other study, two test groups were formed. One included subjects with a hitherto nonvisible disability (n = 29), the other consisted of persons whose disability had already become visible but who had used wheelchairs for only 2 years or less (n = 40). The aim was to study different ways in which subjects in these two groups experienced crisis and what kind of differences occured in it. Subjects with visible disability went through the crisis significantly better than the subjects in the other group. Most of the subjects had known about their diseases for a long time and the disorder itself did not cause their crisis symptoms. These were created by limitations in mobility, and even more so by fear of other people’s attitudes toward disability.

This content is only available via PDF.
© 1991 S. Karger AG, Basel
1991
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.